Vertex Pharmaceuticals (VRTX)

Cash & Short-Term Investments

$7.85B

Quarterly · Period ending: · USD

VRTX logo

VRTX Cash & Short-Term Investments

Latest reported$7.85B
VRTX Quarterly Cash & Short-Term Investments ($4.40M → $7.85B)
High-resolution chart · PNG

VRTX cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
7,852,400,000
7,246,700,000
6,611,100,000
6,287,000,000
6,382,800,000
6,201,200,000
6,115,900,000
6,524,500,000
5,795,500,000
10,171,300,000
11,218,300,000
11,928,200,000
11,236,300,000
10,414,100,000
10,778,500,000
9,770,700,000
9,253,400,000
8,238,100,000
7,524,900,000
6,960,885,000
6,707,993,000
6,923,968,000
6,658,900,000
6,151,058,000
5,450,769,000
4,190,396,000
3,808,294,000
3,996,331,000
3,951,222,000
3,478,035,000
3,168,242,000
3,055,885,000
2,767,755,000
2,477,017,000
2,088,666,000
1,812,248,000
1,668,650,000
1,408,782,000
1,434,557,000
1,128,441,000
1,071,436,000
1,025,618,000
1,042,462,000
1,005,830,000
1,016,450,000
1,181,134,000
1,387,106,000
1,477,737,000
1,219,161,000
1,324,200,000
1,465,076,000
1,422,650,000
1,430,696,000
1,239,354,000
1,321,215,000
1,298,542,000
1,223,334,000
980,867,000
968,922,000
658,685,000
593,491,000
823,452,000
1,031,411,000
1,203,011,000
979,145,000
1,092,683,000
1,284,913,000
856,610,000
754,364,000
869,186,000
832,101,000
920,067,000
832,062,000
749,643,000
460,871,000
502,550,000
592,967,000
655,140,000
704,626,000
694,755,000
262,341,000
339,459,000
361,157,000
399,165,000
446,606,000
334,332,000
386,246,000
418,427,000
460,368,000
520,574,000
583,164,000
595,604,000
633,396,000
680,089,000
634,984,000
651,354,000
679,845,000
699,030,000
743,202,000
381,866,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.